- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
AcelRx Pharmaceuticals is a drug manufacturers - specialty & generic business based in the US. AcelRx Pharmaceuticals shares (ACRX) are listed on the NASDAQ and all prices are listed in US Dollars. AcelRx Pharmaceuticals employs 19 staff and has a trailing 12-month revenue of around $370,000.
What's in this guide?
Our top picks for where to buy AcelRx Pharmaceuticals stock
- Trade $0 commission stocks & ETFs with as little as $1
- Earn up to $300 with qualifying deposits
- Discover new opportunities with Opto's AI-driven thematic investing system
- Theme and ETF screener
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options with no options contract fees
- Get up to $1,000 in stock when you fund a new account within 30 days
- Complimentary access to a financial planner
How to buy AcelRx Pharmaceuticals stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – ACRX. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy AcelRx Pharmaceuticals stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.What is the Finder Score?
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
AcelRx Pharmaceuticals stock price (NASDAQ: ACRX)
Use our graph to track the performance of ACRX stocks over time.AcelRx Pharmaceuticals shares at a glance
52-week range | $0.72 - $1.61 |
---|---|
50-day moving average | $0.76 |
200-day moving average | $0.84 |
Wall St. target price | $4.63 |
PE ratio | N/A |
Dividend yield | N/A |
Earnings per share (TTM) | $-2.75 |
Is it a good time to buy AcelRx Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
AcelRx Pharmaceuticals financials
Revenue TTM | $370,000 |
---|---|
Gross profit TTM | $-3,341,000 |
Return on assets TTM | -32.22% |
Return on equity TTM | -51.12% |
Profit margin | 0% |
Book value | $1.08 |
Market Capitalization | $14.6 million |
TTM: trailing 12 months
AcelRx Pharmaceuticals share dividends
We're not expecting AcelRx Pharmaceuticals to pay a dividend over the next 12 months.
Have AcelRx Pharmaceuticals's shares ever split?
AcelRx Pharmaceuticals's shares were split on a 1:20 basis on 25 October 2022 . So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your AcelRx Pharmaceuticals shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for AcelRx Pharmaceuticals shares which in turn could have impacted AcelRx Pharmaceuticals's share price.
AcelRx Pharmaceuticals share price volatility
Over the last 12 months, AcelRx Pharmaceuticals's shares have ranged in value from as little as $0.72 up to $1.61. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while AcelRx Pharmaceuticals's is 0.517. This would suggest that AcelRx Pharmaceuticals's shares are less volatile than average (for this exchange).
AcelRx Pharmaceuticals overview
AcelRx Pharmaceuticals, Inc. , a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a patient-controlled analgesia system that allows hospital patients with moderate-to-severe acute pain to self-dose with sufentanil sublingual tablets to manage their pain; ARX-02, which is in Phase 2 clinical trial for the treatment of cancer breakthrough pain in opioid-tolerant patients; and ARX-03, which is in Phase 2 clinical trial for the treatment of procedural anxiety and acute pain. Its product candidates also include Niyad, a regional anticoagulant for the extracorporeal circuit; and LTX-608, a nafamostat formulation for direct IV infusion being explored as an investigational product for antiviral treatment of COVID, acute respiratory distress syndrome, disseminated intravascular coagulation, and acute pancreatitis. The company also develops Fedsyra, an ephedrine pre-filled syringe that contains 10 ml of a solution of 3 mg/ml ephedrine hydrochloride for injection; and phenylephrine, a phenylephrine pre-filled syringe, which contains 10 ml of a solution of 50 mcg/ml phenylephrine for injection. The company was formerly known as SuRx, Inc.
Frequently asked questions
nullWhat percentage of AcelRx Pharmaceuticals is owned by insiders or institutions?
Currently 2.637% of AcelRx Pharmaceuticals shares are held by insiders and 38.885% by institutions. How many people work for AcelRx Pharmaceuticals?
Latest data suggests 19 work at AcelRx Pharmaceuticals. When does the fiscal year end for AcelRx Pharmaceuticals?
AcelRx Pharmaceuticals's fiscal year ends in December. Where is AcelRx Pharmaceuticals based?
AcelRx Pharmaceuticals's address is: 25821 Industrial Boulevard, Hayward, CA, United States, 94545 What is AcelRx Pharmaceuticals's ISIN number?
AcelRx Pharmaceuticals's international securities identification number is: US00444T1007 What is AcelRx Pharmaceuticals's CUSIP number?
AcelRx Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 00444T100
More guides on Finder
-
Best Stocks for Beginners With Little Money to Invest
These are the stocks to buy when you don’t have much to spend.
-
Sweep Accounts
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
Trading for Beginners: 9 Best Trading Platforms to Get Started
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
-
5 Top Graphene Stocks to Invest in Today
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
-
10 Best Brokerage Accounts for Trading and Investing in 2024
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
-
Ratings methodology for online brokers
Our star ratings for online brokerages are based on how they stack up in nine key categories.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to Invest $10K
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
Ask a question